PANAXIA LABS ISRAE - stock earnings
PNAX.TA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2022Q4 | -12.5 million ILA | 5.6 million ILA |
2022Q3 | -13.1 million ILA | 10.6 million ILA |
2022Q2 | -8.6 million ILA | 9.5 million ILA |
2022Q1 | -9.1 million ILA | 13.7 million ILA |
2021Q4 | -10.3 million ILA | 23.8 million ILA |
2021Q3 | -6.4 million ILA | 22.5 million ILA |
2021Q2 | 3.6 million ILA | 17.6 million ILA |
2021Q1 | -8.3 million ILA | 19.7 million ILA |
2020Q4 | -9.3 million ILA | 17.0 million ILA |
2020Q3 | -8.4 million ILA | 16.8 million ILA |
2020Q2 | -3.8 million ILA | 3.1 million ILA |
2020Q1 | -9.4 million ILA | 12.2 million ILA |
PNAX.TA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | -43.3 million ILA | 39.4 million ILA |
2021 | -21.4 million ILA | 83.6 million ILA |
2020 | -35.9 million ILA | 60.7 million ILA |
2019 | -81.3 million ILA | 16.7 million ILA |
2018 | 2.7 million ILA | ? ILA |
2017 | -2.3 million ILA | 231000 ILA |
PNAX.TA
Price: ILA9,414
52 week price:
Earnings Per Share: -89.00 ILA
P/E Ratio: -0.46
Exchange: TLV
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 962296
Market Capitalization: 14.4 million